Bank of America’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $989 | Buy |
610
+50
| +9% | +$81 | ﹤0.01% | 6492 |
|
|
2025
Q1 | $402 | Sell |
560
-1,833
| -77% | -$1.32K | ﹤0.01% | 6500 |
|
|
2024
Q4 | $2.66K | Sell |
2,393
-3,478
| -59% | -$3.86K | ﹤0.01% | 6245 |
|
|
2024
Q3 | $4.11K | Sell |
5,871
-19,294
| -77% | -$13.5K | ﹤0.01% | 6114 |
|
|
2024
Q2 | $25.2K | Sell |
25,165
-3,477
| -12% | -$3.48K | ﹤0.01% | 5813 |
|
|
2024
Q1 | $67.9K | Sell |
28,642
-24,899
| -47% | -$59K | ﹤0.01% | 5552 |
|
|
2023
Q4 | $120K | Buy |
53,541
+22,644
| +73% | +$50.9K | ﹤0.01% | 5383 |
|
|
2023
Q3 | $65.5K | Buy |
30,897
+12,151
| +65% | +$25.8K | ﹤0.01% | 5526 |
|
|
2023
Q2 | $57.9K | Sell |
18,746
-35,580
| -65% | -$110K | ﹤0.01% | 5549 |
|
|
2023
Q1 | $292K | Buy |
54,326
+50,384
| +1,278% | +$271K | ﹤0.01% | 4945 |
|
|
2022
Q4 | $26.2K | Buy |
3,942
+2,243
| +132% | +$14.9K | ﹤0.01% | 5868 |
|
|
2022
Q3 | $7K | Buy |
1,699
+244
| +17% | +$1.01K | ﹤0.01% | 6445 |
|
|
2022
Q2 | $8K | Sell |
1,455
-6,213
| -81% | -$34.2K | ﹤0.01% | 6644 |
|
|
2022
Q1 | $47K | Sell |
7,668
-6,392
| -45% | -$39.2K | ﹤0.01% | 6409 |
|
|
2021
Q4 | $163K | Sell |
14,060
-6,189
| -31% | -$71.8K | ﹤0.01% | 5798 |
|
|
2021
Q3 | $318K | Buy |
20,249
+1,307
| +7% | +$20.5K | ﹤0.01% | 5154 |
|
|
2021
Q2 | $353K | Buy |
18,942
+98
| +0.5% | +$1.83K | ﹤0.01% | 4950 |
|
|
2021
Q1 | $813K | Buy |
+18,844
| New | +$813K | ﹤0.01% | 4428 |
|